| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.087 | 0.08 |